The most recently conducted genetic study signalizes that the accumulation of abdominal fat is a major risk factor for development of type 2 diabetes and coronary heart disease (CHD). In particular, the research points that individuals with a genetic predisposition to abdominal type of obesity are at greater risk of elevated triglycerides, serum glucose and arterial blood pressure.
Xarelto (rivaroxaban) is the first and only non-vitamin K antagonist oral anticoagulant. The drug is currently under assessment among high risk patients with coronary or peripheral artery disease. The major news announced by Bayer and Janssen (the developers Xarelto) is that the primary end point of the Phase III COMPASS study of the clinical trial has been met earlier.
Drug approvals are the aimed goal of clinical trials so that they can positively change people’s lives and treat what have been considered incurable. Unfortunately, 2016 has been unsuccessful for newcomers since only 22 medicines have been approved by the U.S. Food and Drug Administration (FDA).
US Food and Drug Administration (FDA) officially announced the approval of the first artificial pancreas for patients with type 1 diabetes. Medtronic’s MiniMed 670G hybrid closed looped system is the first device that automatically tracks the blood glucose (sugar) concentration.
There is one reliable way to minimize the complexity of the financial status of clinical trials and it is better management with appropriate tools. If you haven’t adopted a clinical trial management system (CTMS) yet, then you might be experiencing certain hindrances in your payment relationships.
Organizations, which still use spreadsheets for **trial data collection**, seem to increase the complexity behind the studies they conduct. Sadly, the intricacy of th...
CTMS, or clinical trial management system, works in favor of the optimization of clinical studies, since they grow more complex and varied. It is often that scientists and specialists involved in the process face many struggles due to the requirement to perform various tasks with less resources.
CTMS utilization and implementation in clinical research is of great value for sponsors. In studies they have the sophisticated task to manage budgets and payments correctly and on time. Since this is...
Clinical trial management systems (CTMS) and the industry they are part of have changed drastically. The world they govern will never be the same as they are constantly evolving. Because of the <a hre...
The health industry could not have its contemporary face without the continuous development of new drugs. The research processes include extensive implementation of clinical trials, which are probably the most vital part of the testing and introduction of new medicaments.
